These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 8807798
1. A kinetic study of NMC-A beta-lactamase, an Ambler class A carbapenemase also hydrolyzing cephamycins. Mariotte-Boyer S, Nicolas-Chanoine MH, Labia R. FEMS Microbiol Lett; 1996 Sep 15; 143(1):29-33. PubMed ID: 8807798 [Abstract] [Full Text] [Related]
2. Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase. Papp-Wallace KM, Taracila M, Hornick JM, Hujer AM, Hujer KM, Distler AM, Endimiani A, Bonomo RA. Antimicrob Agents Chemother; 2010 Jul 15; 54(7):2867-77. PubMed ID: 20421396 [Abstract] [Full Text] [Related]
3. Genetic and Biochemical Characterization of FRI-1, a Carbapenem-Hydrolyzing Class A β-Lactamase from Enterobacter cloacae. Dortet L, Poirel L, Abbas S, Oueslati S, Nordmann P. Antimicrob Agents Chemother; 2015 Dec 15; 59(12):7420-5. PubMed ID: 26392482 [Abstract] [Full Text] [Related]
4. [Enzymatic resistance to imipenem in gram-negative bacilli: NMC-A, an original carbapenemase]. Boyer-Mariotte S. Ann Pharm Fr; 1998 Dec 15; 56(6):244-9. PubMed ID: 9872010 [Abstract] [Full Text] [Related]
5. Biochemical Characterization of SFC-1, a class A carbapenem-hydrolyzing beta-lactamase. Fonseca F, Sarmento AC, Henriques I, Samyn B, van Beeumen J, Domingues P, Domingues MR, Saavedra MJ, Correia A. Antimicrob Agents Chemother; 2007 Dec 15; 51(12):4512-4. PubMed ID: 17875998 [Abstract] [Full Text] [Related]
6. Effect of pH on activities of novel beta-lactamases and beta-lactamase inhibitors against these beta-lactamases. Ohsuka S, Arakawa Y, Horii T, Ito H, Ohta M. Antimicrob Agents Chemother; 1995 Aug 15; 39(8):1856-8. PubMed ID: 7486932 [Abstract] [Full Text] [Related]
7. Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam. Piddock LJ, Jin YF, Turner HL. J Antimicrob Chemother; 1993 Jan 15; 31(1):89-103. PubMed ID: 8383105 [Abstract] [Full Text] [Related]
8. Interaction of beta-lactamase inhibitors with various beta-lactamases. Cullmann W. Chemotherapy; 1990 Jan 15; 36(3):200-8. PubMed ID: 2159863 [Abstract] [Full Text] [Related]
9. Kinetics of Sulbactam Hydrolysis by β-Lactamases, and Kinetics of β-Lactamase Inhibition by Sulbactam. Shapiro AB. Antimicrob Agents Chemother; 2017 Dec 15; 61(12):. PubMed ID: 28971872 [Abstract] [Full Text] [Related]
10. Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli. Nordmann P, Mariotte S, Naas T, Labia R, Nicolas MH. Antimicrob Agents Chemother; 1993 May 15; 37(5):939-46. PubMed ID: 8517720 [Abstract] [Full Text] [Related]
11. In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam. Muratani T, Yokota E, Nakane T, Inoue E, Mitsuhashi S. J Antimicrob Chemother; 1993 Sep 15; 32(3):421-9. PubMed ID: 8262864 [Abstract] [Full Text] [Related]
12. Beta-lactamase inhibitors: relation between kinetic data and in-vitro synergism studies. Cullmann W. Zentralbl Bakteriol; 1991 Oct 15; 275(4):500-3. PubMed ID: 1661596 [Abstract] [Full Text] [Related]
13. Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases. Grace ME, Fu KP, Gregory FJ, Hung PP. Drugs Exp Clin Res; 1987 Oct 15; 13(3):145-8. PubMed ID: 3040368 [Abstract] [Full Text] [Related]
14. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors. Tajada P, Gomez-Graces JL, Alós JI, Balas D, Cogollos R. Antimicrob Agents Chemother; 1996 Aug 15; 40(8):1924-5. PubMed ID: 8843305 [Abstract] [Full Text] [Related]
15. Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important beta-lactamases. Payne DJ, Cramp R, Winstanley DJ, Knowles DJ. Antimicrob Agents Chemother; 1994 Apr 15; 38(4):767-72. PubMed ID: 8031044 [Abstract] [Full Text] [Related]
16. Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase. Papp-Wallace KM, Bethel CR, Distler AM, Kasuboski C, Taracila M, Bonomo RA. Antimicrob Agents Chemother; 2010 Feb 15; 54(2):890-7. PubMed ID: 20008772 [Abstract] [Full Text] [Related]
17. Effect of clavulanic acid, sulbactam and tazobactam on three different beta-lactamases from Bacteroides uniformis, Clostridium butyricum and Fusobacterium nucleatum. Hedberg M, Lindqvist L, Tunér K, Nord CE. J Antimicrob Chemother; 1992 Jul 15; 30(1):17-25. PubMed ID: 1331018 [Abstract] [Full Text] [Related]
18. Type I beta-lactamases of Enterobacter cloacae and resistance to beta-lactam antibiotics. Tejedor-Junco MT, González-Martín M, Lupiola P, González-Lama Z. Folia Microbiol (Praha); 1998 Jul 15; 43(6):683-6. PubMed ID: 10069013 [Abstract] [Full Text] [Related]
19. Chromophoric spin-labeled beta-lactam antibiotics for ENDOR structural characterization of reaction intermediates of class A and class C beta-lactamases. Mustafi D, Hofer JE, Huang W, Palzkill T, Makinen MW. Spectrochim Acta A Mol Biomol Spectrosc; 2004 May 15; 60(6):1279-89. PubMed ID: 15134725 [Abstract] [Full Text] [Related]
20. Kinetic analysis of an inhibitor-resistant variant of the OHIO-1 beta-lactamase, an SHV-family class A enzyme. Lin S, Thomas M, Shlaes DM, Rudin SD, Knox JR, Anderson V, Bonomo RA. Biochem J; 1998 Jul 15; 333 ( Pt 2)(Pt 2):395-400. PubMed ID: 9735103 [Abstract] [Full Text] [Related] Page: [Next] [New Search]